Nyxoah is trading at $0.88, up 6.96%, with no clear company-specific news identified to explain the October 23 pre-market rise.

  • On October 19, Nyxoah lowered its 2026 revenue outlook to €33–35 million from €36–40 million, despite preliminary Q3 revenue of about €9.2 million; that update does not establish a reason for today’s rise.
  • Major U.S. indices are lower, so broad-market strength does not explain the gain. No volume or activity data was provided.